Want to see RVPH full AI Analyst Report?
Reviva Pharmaceuticals Holdings (RVPH) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Brilaroxazine | Schizophrenia | Phase III | Recruiting | Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia | Nov 29, 2021 | ― |
| Rp5063, Aripiprazole | Schizoaffective Disorder, Acute Schizophrenia | Phase II | Completed | RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder | Dec 07, 2011 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Brilaroxazine | Phase III | Schizophrenia | Recruiting | Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia | Nov 29, 2021 | ― |
| Rp5063, Aripiprazole | Phase II | Schizoaffective Disorder, Acute Schizophrenia | Completed | RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder | Dec 07, 2011 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Reviva Pharmaceuticals Holdings, Inc. (RVPH) have in its pipeline
Reviva Pharmaceuticals Holdings RVPH is currently developing the following drugs: Brilaroxazine, Rp5063, Aripiprazole. These drug candidates are in various stages of clinical development as the company works toward FDA approval.